top of page

Pouya Faridi

Dr Pouya Faridi

Therapeutic cancer vaccination is an emerging approach for incurable cancers. It can train the immune system to find and destroy tumours. However, the most challenging part of any vaccination strategy is identifying an appropriate vaccine target on the surface of a tumour. Dr Faridi and his team have developed new technologies to identify novel targets for cancer vaccines. His laboratory uses proteomics, immunopeptidomics and systems biology techniques to discover novel proteins and peptides as DIPG-specific vaccine targets. They use preclinical models, patients’ tumours, and blood samples for vaccine target identification. The ultimate goal of his laboratory is to develop off-the-shelf vaccines for DIPG/DMG. These vaccines might be used as monotherapy or combined with other treatment strategies such as radiotherapy and epigenetic modulators.

Associate Professor

Misty Jenkins,

WEHI

Dr Ryan Duchatel,

University of Newcastle

Dr Jason Cain,

Hudson institute

for Medical Research

Professor
Lee Wong,
Monash University

Professor
Peter Rogers,
University of Melbourne

Associate Professor Jeffrey Mann,
Monash University

Other research grant recipients

Contact Us

Email:

info@isabella

andmarcus

foundation.org

Khush De Rose:

0434 430 035

Daniela Ruberto:

0412 339 673

For media enquiries:

Robert De Rose:

0422 625 913

Address

4 Stephen Rd,

Dandenong South,

Victoria 3175

Follow Us

The Isabella and Marcus Foundation

@isabellamarcusfoundation

Isabella and Marcus Foundation

© 2024 by Isabella and Marcus Foundation

Contact Us

Email:

info@isabellaandmarcusfoundation.org

Khush De Rose: 0434 430 035

Daniela Ruberto: 0412 339 673

For media enquiries:

Robert De Rose: 0422 625 913

Address

4 Stephen Rd,

Dandenong South,

Victoria 3175

Follow Us

The Isabella and Marcus Foundation

@isabellamarcusfoundation

Isabella and Marcus Foundation

© 2024 by Isabella and Marcus Foundation

bottom of page